Psychiatry

The State of the Art Volume 3 Pharmacopsychiatry
Herausgegeben:Pichot, P.

• Broschiertes Buch

Produktbeschreibung

The purpose of the World Psychiatric Association is to coordinate the activities of its Member Societies on a world-wide scale and to advance enquiry into the etiology, pathology, and treatment of mental illness. To further this purpose, the Association organizes mono- or multi thematic Regional Symposia in different parts of the world twice a year, and World Congresses dealing with all individual fields of psychiatry once every five or six years. Between these meetings the continuation of the Association's scientific work is assured through the activities of its specialty sections, each covering an important field of psychiatry. The programs of the World Congresses reflect on the one hand the intention to present the coordinating functions of the Association and on the other to open a broad platform for a free exchange of views. Thus, the VII World Congress of Psychiatry, held in Vienna from July 11 to 16, 1983, was composed of two types of scientific events - those structured by the Association and those left to the initiative of the participants. The first type comprised Plenary Sessions, planned by the Scientific Program Committee, and Section Symposia, organized by the WPA sections; the second embraced Free Symposia, free papers, video sessions, and poster presentations prepa~ed by the participants. Altogether, 10 Plenary Sessions, 52 Section Symposia, and 105 Free Symposia took place, and 78 free papers and poster sessions and 10 video sessions were held.

Produktdetails

• Verlag: Springer / Springer US / Springer, Berlin
• Artikelnr. des Verlages: 978-1-4612-9446-7
• Softcover reprint of the original 1st ed. 1985
• Seitenzahl: 888
• Erscheinungstermin: 4. Oktober 2011
• Englisch
• Abmessung: 254mm x 178mm x 48mm
• Gewicht: 1634g
• ISBN-13: 9781461294467
• ISBN-10: 1461294460
• Artikelnr.: 39561911

Inhaltsangabe

Pharmaco EEG and Psychometry in Early Psychopharmacology.- Psychometry in Early Psychopharmacology.- On the Value of CNS, ANS and Behavorial Measures in Early Clinical Psychopharmacology.- The Multivariate Approach in Pharmaco-EEG and ERP Research.- Phase-IV Research in Psychiatry: Methodology and Objectives.- Phase-IV Research in Psychiatry: Research Objectives and Methodology.- Symptoms, Cognitions and Biology in General Practice Patients.- Studies in General Practice: Interpractice Differences.- The Private Practice Study Group as Phase-IV Research Tool.- The Outpatient Clinic as Phase-IV Research Tool.- Drug Monitoring in Psychiatric Hospitals.- Drug Strategies for Altering Cognitive Functions.- Psychopathology of Cognition.- The Cholinergic Basis of Memory - A Reappraisal.- Behavioral Effects of Vasopressin Treatment: Cognitive Implications.- The Relationship Between Depressive and Cognitive Disorders and Treatment with Nomifensine.- Cognitive Analysis of Neuropharmacological Treatments.- Predictors - New Antidepressants.- Is the TRH Test a Predictor and Parameter of the Therapeutic Response to Antidepressive Treatment?.- Treatment of Therapy-Resistant Depression.- Some General Remarks to the Problem of Therapy Resistant Depressions.- The Tyramine Pressor Test in Depressive Illness and Their Treatment with Antidepressants.- Biochemical Effects of Carbamazepine: Possible Mechanisms of Action in Affective and Seizure Disorders.- Atypical Depression Following Maternal Deprivation.- Treatment of Therapy-Resistant Depression with Drip Infusions.- Depression and its Treatment in the Problem Patient-Experiences with Bupropion, A New-Generation Antidepressant.- The Pharmacological Rationale for Bupropion.- Endogenous Depression and Response to Antidepressants.- Problems in the Treatment of the Chronic Depressive.- Plasma Monitoring of Antidepressants.- Anxiety Control Without Sedation in Depressed Patients Treated with Bupropion.- Weight Gain and Sexual Dysfunction During Treatment of Depression.- Early Onset of Action and Safety in Antidepressant Therapy with Trazodone - New Clinical Data.- Trazodone - A Distinctive Pharmacological Profile.- Trazodone and Mianserin in General Practice.- Trazodone-Induced Ventricular Arrhythmias: Fact or Artifact.- Acute Trazodone Poisoning: Clinical Signs and Plasma Concentrations.- Pirlindole in the Management of Depressed Patients in Clinical Practice.- The Novel Antidepressant Pirlindole: A Pharmacological Profile.- About the Central Effect of Pirlindole, A New Antidepressant.- The Pharmacokinetics of Pirlindole in Man.- Effect of Pirlindole on Endocrine Parameters in Healthy Man.- The Effect of Pirlindole on the Visually Evoked Cortical Potential (VECP) in Man.- Is There a Tyramine Potentiating Effect of Pirlindole?.- Studies of the Effects of Pirlindole on Sleep.- Placebo-Controlled Investigation on the Effects of Pirlindole on Sensorimotor Performance and Subjective Condition in Comparison to Imipramine and Under the Influence of Ethanol.- Pirlindole in Depression: An Open Clinical Study.- Long-Term Tolerance of Pirlindole in Patients with Chronic Schizophrenia and Accompanying Depressive Symptomatology.- Clinical Trials with the New Antidepressant Pirlindole in Patients with Depression and Various Psychiatric Diseases.- Dosage and Efficacy of the Antidepressant Pirlindole in 15 Female In-Patients with Depressive Syndrome.- Efficacy and Tolerance of Pirlindole in 20 Male In-Patients with Psychosis: Organic Brain Dysfunction and Accompanying Depression.- Pirlindole: Results of an Open Clinical Study in Out-Patients and of a Double-Blind Study Against Maprotiline.- Examining Pharmaco EEG-Based Predictions About the Antidepressant Action of Pirlindol by Double Blind Clinical Trials.- A Double Blind Comparison of Pirlindole with Amitriptyline and Imipramine.- A Double-Blind Comparative Study of Pirlindole and Amitriptyline in 30 Depressive Patients.- A Comparison of Pirlindole and Amitriptyline in a Double-Blind Controlled Study.- EEG Changes Induced by Amitriptyline and Pirlindole in Endogenous Depression.- A Double-Blind Comparative Study on the Use of 225 mg Pirlindole and 150 mg Desipramine in the Treatment of Depressive Inpatients.- Antidepressive Efficacy of Pirlindole in Man.- Effect of a Single Dose of 225 mg Pirlindole on Intraocular Pressure and Diameter of Pupils in 10 Patients with Eye Disease Without Primary Raise in Intraocular Pressure.- Psychopharmacology of Suicidal Behaviour.- Psychopharmacology of Suicide: The Background.- The Prevention of Attempts in High Risk Suicidal Patients.- Thyrotrophin Response to Thyreostimulin and Suicidal Behaviour.- Cerebrospinal Fluid Amine Metabolites and Neuroendocrine Findings: Biochemical Markers in Suicide?.- Psychotic Disorders Responsive to Lithium.- to Psychotic Disorders Responsive to Lithium.- A Biological Test Which Distinguishes Lithium Responsive Psychoses.- The Use of Lithium in the Long Term Morbidity Suppressive Treatment of Cycloid and Schizoaffective Psychoses.- LI-Responsive Psychosis: Family Studies.- Psychotic Disorders Responsive to Lithium: Clinical Features.- Lithium Ratio and Lithium Response in the Psychoses.- Membranes. Lipids and the Lithium-Responsive Psychoses.- Lithium: Withdrawal Studies, Treatment of Non-Responders.- Lithium Withdrawal Triggers Psychosis.- Lithium Discontinuation: Side-Effects, Withdrawal Symptoms, Rebound Effect.- What Follows Lithium Withdrawal?.- New Approaches to the Treatment of Lithium Non-Responders.- RBC-Choline: Relation to Clinical Lithium Response.- The Use of Anticonvulsants in Affective Disorders.- On the Interaction of Carbamazepine with Catecholamine Metabolism: Implication for Psychopharmacological and Behavioural Effects.- Effect of Valproate on In Vivo Gaba-Turnover.- The Use of Valproate and Oxcarbazepine in Affective Disorders.- Efficacy of Valproate in Manic-Depressive Psychosis: Mechanism of Action and Implications for Pathophysiology.- Therapeutic and Prophylactic Efficacy of Carbamazepine in Affective Disorders.- Prophylactic Efficacy of Carbamazepine in Affective Disorders.- Carbamazepine: Treatment of Affective Illness and Anxiety Syndromes.- Carbamazepine in Excited Psychoses.- Prophylactic Treatment of Affective Disorders with Carbamazepine and Oxcarbazepine: An Open Clinical Trial.- Oxcarbazepine in Acute Mania.- Calcium Antagonists in Mania: A Preliminary Clinical Report.- Pet-Investigation in Anorexia Nervosa: Preliminary Results.- The GABA System of the Mammalian CNS.- Benzodiazepine Receptor: Structural Aspects and Modes of Ligand Interactions.- Interactions of Benzodiazepines with the GABA System.- Usefulness and Limitations of Benzodiazepine Pharmacokinetics for Clinical Practice.- Brain Receptor Occupation and Kinetics of Benzodiazepine Action.- Alternatives to Minor Tranquilizers in Depression.- Therapeutic Alternatives in Depression.- Therapeutic Alternatives in Psychosomatic Cardiovascular Disorders.- Therapeutic Alternatives in Other Psychosomatic Disorders.- Alternatives to Treatment with Minor Tranquilizers in Adolescent Patients.- Alternatives to Treatment with Minor Tranquilizers in Psychogeriatics.- Alternatives to Treatment with Minor Tranquilizers in Organic Diseases.- Recent Developments in Substituted Benzamide Drugs.- to the Symposium "Recent Developments in Substituted Benzamide Drugs".- Selective Actions of Substituted Benzamide Drugs on Brain Dopamine Receptors.- Neuroleptics and Drug-Induced Modifications of Behaviour in Animals and Men.- The Dopaminergic Receptors and Their Interaction with Neuroleptics and Benzamide Compounds.- Bipolar Effects of Sulpiride.- Present Use of Sultopride in Psychiatry.- Double Blind Study to Compare Activity and Tolerance of Sultopride and Haloperidol in Agitated States: Report on 46 Cases.- Sultopride in the Treatment of Psychiatric Disorders in Children and Adolescents.- Clinical Experience in the Treatment of Tardive Dyskinesia with Tiapride.- Tiapride Treatment in Extrapyramidal Disorders and in Pain Syndromes.- Treatment of Acute Withdrawal Syndrome with Tiapride.- Tiapride and Chlormethiazole in Alcohol Withdrawal: A Double-Blind Trial.- Determination of Pharmacokinetics and Pharmacodynamics of Amisulpride by Pharmaco-EEG and Psychometry.- A Double Blind Comparison of Amisulpride vs. Haloperidol in Acute Schizophrenic Patients.- Clinical Evaluation of Prosulpride in Depressive States.- Effects of Sulpiride in Schizophrenic Patients.- Substituted BEnzamides in the Treatment of Acute Oneiric and Confusional Psychoses.- Combined or Sequential Use of Sulpiride and Sultopride-Intravenous Administration of Sulpiride.- Conclusion of the Symposium "Rencent Developments in Substituted Benzamide Drugs".- Modern Trends in the Chemotherapy of Schizophrenia.- Pharmacokinetics of Oral and Depot Neuroleptics.- CIS(Z)-Clopenthixol in the Treatment of Acute Schizophrenia.- The Management of the Schizophrenic Patient in the U.K. "Model Unit" in Community Psychiatry Worcester.- Maintenance Treatment of Chronic Schizophrenia.- Is Additional Medication Required in the Maintenance Treatment of Schizophrenia?.- Effect of Neuroleptic Withdrawl During the Maintenance Treatment of Chronic Schizophrenics.- Special Patient Populations and their Unique Treatment Demands.- A Double-Blind Controlled Clinical Trial of Haloperidol Decanoate and Fluphenazine Decanoate in the Maintenance Treatment of Schizophrenia.- Depot Medication in Chronic Schizophrenia.- Depot-Neuroleptics in Acute Psychiatry.- Depot Neuroleptics as Tranquilizers.- Biochemical and Neuroendocrinological Effects of Chronic Neuroleptic Treatment.- Demands and Expectations of Depotneuroleptics in Social Psychiatry.- International Workshop "NB 106-689-A Non-Classical Neuroleptic".- Pharmacology of Fluperlapine Compared with Clozapin.- NB 106-689(Fluperlapine) in 104 Schizophrenic Patients (Open Multicenter Trial).- Addendum.- Anxiety or Depression: Which Should You Treat? The Unmasking and Treatment of Anxiety in Depression.- Relapses of Manic-Depressive Disorders Triggered by Abrupt Lithium Withdrawal.- The Challenge of Lithium Discontinuation.- Carbamazepine in Violent Schizophrenics.- The Use of Valpromide in Affective Disorders (Acute and Prophylactic Therapies).- Comparative Studies of the Effect of Carbamazepin and Trimipramin on Depressions.- Carbamazepine: A Possible Alternative in Lithium-Resistant Bipolar Disorder.- Author Index.- of Volume I-VIII.